Roche (OTCMKTS:RHHBY) Stock Passes Above Fifty Day Moving Average – What’s Next?

Roche Holding AG (OTCMKTS:RHHBY)’s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $52.13 and traded as high as $57.57. Roche shares last traded at $57.26, with a volume of 1,356,317 shares.

Analyst Ratings Changes

Several analysts have recently issued reports on RHHBY shares. HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a research report on Monday, July 6th. Zacks Research downgraded Roche from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 14th. Finally, Morgan Stanley raised Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price objective for the company in a research note on Friday. Five analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $60.00.

Roche Price Performance

The company’s fifty day moving average price is $52.13 and its 200-day moving average price is $52.89. The company has a quick ratio of 1.12, a current ratio of 1.38 and a debt-to-equity ratio of 0.72.

Institutional Trading of Roche

Several institutional investors have recently added to or reduced their stakes in RHHBY. Confluence Investment Management LLC grew its stake in Roche by 1.2% in the second quarter. Confluence Investment Management LLC now owns 20,925 shares of the company’s stock valued at $1,074,000 after purchasing an additional 258 shares during the last quarter. Oakworth Capital Inc. boosted its holdings in Roche by 20.8% in the fourth quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock worth $86,000 after acquiring an additional 285 shares in the last quarter. Enterprise Financial Services Corp grew its stake in shares of Roche by 6.6% during the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after acquiring an additional 345 shares during the last quarter. Archer Investment Corp increased its holdings in shares of Roche by 7.7% during the first quarter. Archer Investment Corp now owns 5,598 shares of the company’s stock valued at $278,000 after acquiring an additional 398 shares in the last quarter. Finally, Diversified Trust Co raised its position in shares of Roche by 0.8% in the 1st quarter. Diversified Trust Co now owns 59,375 shares of the company’s stock valued at $2,907,000 after purchasing an additional 448 shares during the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.